The Patent Finder

Camurus AB

35 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 4 name spellings.

13
Ending by 2030
Jan 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 3 fees due Dec 13 to 30, 2026 · next Dec 13

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,236,292Liquid depot formulations
In force
 · USPTO record
In forceUSPTO record
US 8,182,834Ternary non-lamellar lipid compositions
In force
 · USPTO record
In forceUSPTO record
US 9,757,461GnRH analogue formulations
In force
 · USPTO record
In forceUSPTO record
US 8,871,712Somatostatin analogue formulations
In force
 · USPTO record
In forceUSPTO record
US 8,865,021Compositions of lipids and cationic peptides
In force
 · USPTO record
In forceUSPTO record
US 8,097,239Controlled-release formulations
In force
 · USPTO record
In forceUSPTO record
US 9,060,935Pharmaceutical lipid compositions
In force
 · USPTO record
In forceUSPTO record
US 8,541,400Compositions forming non-lamellar dispersions
In force
 · USPTO record
In forceUSPTO record
US 8,546,326Glp-1 analogue formulations
In force
 · USPTO record
In forceUSPTO record
US 9,974,861Peptide Slow-Release Formulations
In force
 · High confidence
In forceHigh confidence
10 of 35 patents shown.
Pro members see all 35.
Pro members: see all 35 patents
Also on record, not counted in the 35: 1 lapsed for an unpaid fee · 8 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 4 abandoned · 24 no status recorded

Showing 1 to 10 of 34, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/056,414Mixtures and Formulations Comprising an Alkyl Ammonium Edta SaltFeb 18, 2025Pending
19/028,414Lipid-Controlled Release CompositionsJan 17, 2025Pending
18/988,085Dec 19, 2024No status recorded
18/945,113Prostacyclin Analogue FormulationsNov 12, 2024Pending
18/889,001Controlled Release Peptide FormulationsSep 18, 2024Pending
18/665,039Peptide Slow-Release FormulationsMay 15, 2024Abandoned
18/500,603Nov 1, 2023No status recorded
18/307,124Apr 26, 2023No status recorded
18/161,828Mixtures and FormulationsJan 30, 2023Pending
17/836,120Jun 9, 2022No status recorded
10 of 34 applications shown.
Pro members see all 34 published applications.
Pro members: see all 34 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited